Skip to main content

Publisher: Cognizant Communication Corporation

Volume 15, Number 2, 2000

Characterization of anticancer agents by their growth inhibitory activity and relationships to mechanism of action and structure
pp. 79-98(20)
Authors: Keskin, O; Bahar, I; Jernigan, RL; Beutler, JA; Shoemaker, RH; Sausville, EA; Covell, DG


Biological properties of 5,11-dimethyl-6H-pyrido[3,2-b]carbazoles: a new class of potent antitumor drugs
pp. 109-118(10)
Authors: Moinet-Hedin, V; Tabka, T; Poulain, L; Godard, T; Lechevrel, M; Saturnino, C; Lancelot, J-C; Le Talaël, J-Y; Gauduchon, P


Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agents
pp. 119-126(8)
Authors: Anderson, FM; O'Hare, CC; Hartley, JA; Robins, DJ


Novobiocin-induced VP-16 accumulation and MRP expression in human leukemia and ovarian carcinoma cells
pp. 127-134(8)
Authors: Rappa, G; Murren, JR; Johnson, L-M; Lorico, A; Sartorelli, AC


The interaction of chalcones with tubulin
pp. 135-141(7)
Authors: Lawrence, NJ; McGown, AT; Ducki, S; Hadfield, JA


Photosensitizing properties of palladium-tetraphenylporphycene on cultured tumour cells
pp. 143-150(8)
Authors: Cañete, M; Ortiz, A; Juarranz, A; Villanuev, A; Nonell, S; Borrell, JI; Teixidó, J; Stockert, JC


The complete issue is available for purchase


Purchasing this issue will give you access to all of the articles listed above for 2 days. You may also purchase articles individually by visiting the abstract page of the article. The exact price (including tax) will be displayed in your shopping cart before you check out. You will be able to remove this item from your shopping cart at any time before you have completed check-out.

Add to cart

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more